Disorders of Tyrosine Metabolism

作者: Anupam Chakrapani , Elisabeth Holme

DOI: 10.1007/978-3-540-28785-8_18

关键词:

摘要: Five inherited disorders of tyrosine catabolism are known and depicted in Fig. 15.1. Hereditary tyrosinaemia type I is characterized by progressive liver disease renal tubular dysfunction with rickets. II (Richner-Hanhart syndrome) presents keratitis blisterous lesions the palms soles. Tyrosinaemia III may be asymptomatic or associated mental retardation. Hawkinsinuria failure to thrive metabolic acidosis infancy. In alkaptonuria symptoms osteoarthritis usually appear at an advanced age. Other inborn errors metabolism include oculocutaneous albinism caused a deficiency melanocyte-specific tyrosinase, converting into DOPA-quinone; hydroxylase, first enzyme synthesis dopamine from tyrosine; aromatic l-amino acid decarboxylase, which also affects tryptophan metabolism. The latter two covered Chap. 26.

参考文章(125)
L. A. Mieles, C. O. Esquivel, D. H. Van Thiel, B. Koneru, L. Makowka, A. G. Tzakis, T. E. Starzl, Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh. Digestive Diseases and Sciences. ,vol. 35, pp. 153- 157 ,(1990) , 10.1007/BF01537237
Marian S Macsai, Terry L Schwartz, David Hinkle, Mary Beth Hummel, Mark G Mulhern, David Rootman, Tyrosinemia type II: nine cases of ocular signs and symptoms American Journal of Ophthalmology. ,vol. 132, pp. 522- 527 ,(2001) , 10.1016/S0002-9394(01)01160-6
Maurice M. Pomeranz, Lewis J. Friedman, Isidore S. Tunick, Roentgen Findings in Alkaptonuric Ochronosis Radiology. ,vol. 37, pp. 295- 303 ,(1941) , 10.1148/37.3.295
Yngve T. Bliksrud, Amund Ellingsen, Magnar Bjørås, Fumarylacetoacetate inhibits the initial step of the base excision repair pathway: implication for the pathogenesis of tyrosinemia type I. Journal of Inherited Metabolic Disease. ,vol. 36, pp. 773- 778 ,(2013) , 10.1007/S10545-012-9556-0
W. Dihlmann, H. Greiling, R. Kisters, H. W. Stuhlsatz, Biochemical and radiological studies on the pathogenesis of alkaptonuria Deutsche Medizinische Wochenschrift. ,vol. 95, pp. 839- 844 ,(1970) , 10.1055/S-0028-1108550
D G Barr, J M Kirk, S C Laing, Outcome in tyrosinaemia type II. Archives of Disease in Childhood. ,vol. 66, pp. 1249- 1250 ,(1991) , 10.1136/ADC.66.10.1249
Fumio Endo, Akito Kitano, Itsuko Uehara, Noriyuki Nagata, Ichiro Matsuda, Toshihiro Shinka, Tomiko Kuhara, Isamu Matsumoto, Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia. Pediatric Research. ,vol. 17, pp. 92- 96 ,(1983) , 10.1203/00006450-198302000-00002
S. Santra, M. A. Preece, S.-A. Hulton, P. J. McKiernan, Renal tubular function in children with tyrosinaemia type I treated with nitisinone Journal of Inherited Metabolic Disease. ,vol. 31, pp. 399- 402 ,(2008) , 10.1007/S10545-008-0817-X
S.M. Pasternack, R.C. Betz, F. Brandrup, E.F. Gade, O. Clemmensen, A.M. Lund, E. Christensen, A. Bygum, Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II. British Journal of Dermatology. ,vol. 160, pp. 704- 706 ,(2009) , 10.1111/J.1365-2133.2008.08888.X